Profil is the world's leading full service CRO for metabolic research. Our research focuses on early phase clinical trials within diabetes, obesity and NAFLD/NASH. Due to this specialization we can offer a unique combination of scientific excellence, reliable and fast patient recruitment and sophisticated methodologies to deliver a premium quality service tailored to your needs.
As a full service provider we can design and conduct clinical studies from start to finish, if desired. Due to our expertise in pharmacology, nutritional sciences, cardiometabolic research, hepatology and endocrinology, we carry out the best-in-class trials for our clients.
One of our core technologies is the hyperinsulinemic euglycemic clamp, used to address action profiles of insulin and insulin analogues, beta cell function and insulin sensitivity. To be able to offer the best services for any glucose clamping setup, we have developed ClampArt®, the next generation of glucose clamping.
As a full service provider we can design and conduct clinical studies from start to finish, if desired. Due to our expertise in pharmacology, nutritional sciences, cardiometabolic research, hepatology and endocrinology, we carry out the best-in-class trials for our clients.
One of our core technologies is the hyperinsulinemic euglycemic clamp, used to address action profiles of insulin and insulin analogues, beta cell function and insulin sensitivity. To be able to offer the best services for any glucose clamping setup, we have developed ClampArt®, the next generation of glucose clamping.
Focus Areas
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
